Turn Therapeutics TTRX
NASDAQ TTRX
$10.27 +0.13 (+1.23%)
As of: Oct 22, 2026 · 9:42 AM EDT

Turn Therapeutics (TTRX) Intangibles (2024 - 2026)

Updated

Turn Therapeutics (TTRX) recorded Intangibles of $911,219 in Q2 2026, down 0.9% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Intangibles (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics reported Intangibles of $922,171, up 12.2% from FY2024.

  • Across earlier years, Intangibles came in at $821,931 in FY2024.
  • Quarterly Intangibles has ranged from $821,931 in Q4 2024 to $922,171 in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $919,947 (Q1 2026), $922,171 (Q4 2025) and $904,885 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 18.11 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn 48.23 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn 49.14 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 24.98 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 42.07 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 37.72 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn 20.49 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn 14.03 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 47.05 Bn
10 Turn Therapeutics 306.07 Mn 279.18 Mn - 911,219.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 911,219.00
Mar 31, 2026 919,947.00
Dec 31, 2025 922,171.00
Sep 30, 2025 904,885.00
Dec 31, 2024 821,931.00
API Access

Turn Therapeutics Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=TTRX&period=max&api_key=YOUR_API_KEY